The Necrotic Enteritis Treatment Market is estimated to be valued at USD 30.8 billion in 2025 and is projected to reach USD 61.6 billion by 2035, registering a compound annual growth rate (CAGR) of 7.2% over the forecast period.
| Metric | Value |
|---|---|
| Necrotic Enteritis Treatment Market Estimated Value in (2025 E) | USD 30.8 billion |
| Necrotic Enteritis Treatment Market Forecast Value in (2035 F) | USD 61.6 billion |
| Forecast CAGR (2025 to 2035) | 7.2% |
The Necrotic Enteritis Treatment market is experiencing steady growth driven by the high prevalence of necrotic enteritis in poultry and livestock, which is leading to substantial economic losses in the livestock industry. Increasing awareness among farmers and veterinarians about disease management and animal welfare has resulted in heightened demand for effective therapeutic solutions. Advancements in veterinary pharmacology and the availability of targeted drug classes have improved treatment outcomes, further encouraging adoption.
In addition, the expansion of commercial poultry and livestock operations globally has created a strong need for scalable and efficient treatment methods. The market is also being supported by regulatory measures emphasizing preventive care and safe drug usage in animals.
Ongoing research into novel antibiotic formulations and alternative therapies is expected to enhance treatment efficacy and provide more options to veterinarians and producers As animal husbandry continues to intensify and focus on productivity and disease control, the Necrotic Enteritis Treatment market is positioned to maintain steady growth with opportunities for innovation in drug classes and distribution channels.
The necrotic enteritis treatment market is segmented by drug class, distribution channel, and geographic regions. By drug class, necrotic enteritis treatment market is divided into Necrotic Enteritis Treatment Through Antibiotics, Necrotic Enteritis Treatment Through Inter-Alpha-Inhibitor-Proteins ("IaIp"), and Necrotic Enteritis Treatment Through Dietary Supplements. In terms of distribution channel, necrotic enteritis treatment market is classified into Necrotic Enteritis Treatment Sales Via Hospital Pharmacies, Necrotic Enteritis Treatment Sales Via Retail Pharmacies, Necrotic Enteritis Treatment Sales Via Online Pharmacies, and Necrotic Enteritis Treatment Sales Via Drug Stores. Regionally, the necrotic enteritis treatment industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The Necrotic Enteritis Treatment Through Antibiotics segment is projected to hold 45.0% of the market revenue share in 2025, making it the leading drug class. This dominance is being driven by the established efficacy of antibiotics in controlling bacterial proliferation, preventing disease progression, and reducing mortality in infected poultry and livestock. Antibiotics are preferred due to their fast action, reliable outcomes, and ease of administration, which allows timely intervention in large-scale commercial operations.
The segment’s growth is further supported by veterinary guidelines that recommend targeted antibiotic use for effective disease management. Additionally, antibiotics provide flexible dosage options and compatibility with feed and water-based delivery systems, making them convenient for producers.
The widespread acceptance of antibiotics as a first-line therapy has reinforced this segment’s market leadership, with ongoing research aimed at developing more potent and safer formulations The combination of proven efficacy, availability, and adaptability to various livestock environments has ensured that antibiotic-based treatment remains the dominant choice for managing necrotic enteritis.
The Necrotic Enteritis Treatment Sales Via Hospital Pharmacies segment is anticipated to account for 40.0% of the market revenue share in 2025, emerging as the leading distribution channel. This prominence is being attributed to the reliability and professional oversight provided by hospital pharmacies, ensuring accurate prescription, dosage, and safe handling of therapeutic drugs. Hospital pharmacies are preferred by veterinarians and commercial poultry producers because they offer access to certified drugs, maintain quality standards, and reduce the risk of counterfeit or substandard products.
The growth of this segment is further supported by structured supply chains that ensure timely delivery to animal farms and veterinary clinics. Centralized procurement and inventory management systems in hospital pharmacies allow bulk orders and consistent availability of high-demand drugs, improving treatment efficiency.
Additionally, hospital pharmacies provide guidance on disease management protocols and regulatory compliance, enhancing trust among producers The combination of professional support, product quality assurance, and reliable distribution has cemented hospital pharmacies as the preferred channel for necrotic enteritis treatment, driving consistent revenue share growth in the market.
Necrotic enteritis, also known as necrotizing enterocolitis, is an inflammatory bowel disease that affects prematurely born babies. Premature infants are those who are born before 37 weeks of pregnancy. According to the World Health Organization (WHO), approximately 15 million premature babies are born worldwide each year, with the number steadily increasing, and approximately 1 million babies die as a result of this condition.
India has the highest number of preterm births, followed by China, Nigeria, Pakistan, Indonesia, the United States, Bangladesh, the Philippines, Congo, and Brazil. Although the causes of necrotic enteritis are unknown, in December 2025, researchers at Johns Hopkins University School of Medicine discovered the molecular cause of the condition, which is likely to be related to brain injury.
Necrotic enteritis is more likely to occur in prematurely born infants who have been infected. Necrotic enteritis affects 10–12% of prematurely born infants and the majority of cases result in death.
| Country | CAGR |
|---|---|
| China | 9.7% |
| India | 9.0% |
| Germany | 8.3% |
| France | 7.5% |
| UK | 6.8% |
| USA | 6.1% |
| Brazil | 5.4% |
The Necrotic Enteritis Treatment Market is expected to register a CAGR of 7.2% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 9.7%, followed by India at 9.0%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 5.4%, yet still underscores a broadly positive trajectory for the global Necrotic Enteritis Treatment Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 8.3%. The USA Necrotic Enteritis Treatment Market is estimated to be valued at USD 11.2 billion in 2025 and is anticipated to reach a valuation of USD 20.2 billion by 2035. Sales are projected to rise at a CAGR of 6.1% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 1.7 billion and USD 974.8 million respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 30.8 Billion |
| Drug Class | Necrotic Enteritis Treatment Through Antibiotics, Necrotic Enteritis Treatment Through Inter-Alpha-Inhibitor-Proteins ("IaIp"), and Necrotic Enteritis Treatment Through Dietary Supplements |
| Distribution Channel | Necrotic Enteritis Treatment Sales Via Hospital Pharmacies, Necrotic Enteritis Treatment Sales Via Retail Pharmacies, Necrotic Enteritis Treatment Sales Via Online Pharmacies, and Necrotic Enteritis Treatment Sales Via Drug Stores |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | PPG, BASF, Sherwin Williams, Mankiewicz, AkzoNobel, Henkel, Hentzen, MAPAERO, Permagard, Dunmore, Hexion, and Polymer Technologies |
The global necrotic enteritis treatment market is estimated to be valued at USD 30.8 billion in 2025.
The market size for the necrotic enteritis treatment market is projected to reach USD 61.6 billion by 2035.
The necrotic enteritis treatment market is expected to grow at a 7.2% CAGR between 2025 and 2035.
The key product types in necrotic enteritis treatment market are necrotic enteritis treatment through antibiotics, necrotic enteritis treatment through inter-alpha-inhibitor-proteins (iaip) and necrotic enteritis treatment through dietary supplements.
In terms of distribution channel, necrotic enteritis treatment sales via hospital pharmacies segment to command 40.0% share in the necrotic enteritis treatment market in 2025.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Infectious Enteritis Treatment Market
Treatment-Resistant Hypertension Management Market Size and Share Forecast Outlook 2025 to 2035
Treatment-Resistant Depression Treatment Market Size and Share Forecast Outlook 2025 to 2035
Treatment Pumps Market Insights Growth & Demand Forecast 2025 to 2035
Pretreatment Coatings Market Size and Share Forecast Outlook 2025 to 2035
Air Treatment Ozone Generator Market Size and Share Forecast Outlook 2025 to 2035
CNS Treatment and Therapy Market Insights - Trends & Growth Forecast 2025 to 2035
Seed Treatment Materials Market Size and Share Forecast Outlook 2025 to 2035
Acne Treatment Solutions Market Size and Share Forecast Outlook 2025 to 2035
Scar Treatment Market Overview - Growth & Demand Forecast 2025 to 2035
Soil Treatment Chemicals Market
Water Treatment Market Size and Share Forecast Outlook 2025 to 2035
Water Treatment Ozone Generator Market Size and Share Forecast Outlook 2025 to 2035
Water Treatment Equipment Market Size and Share Forecast Outlook 2025 to 2035
Burns Treatment Market Overview – Growth, Demand & Forecast 2025 to 2035
CRBSI Treatment Market Insights - Growth, Trends & Forecast 2025 to 2035
Water Treatment Polymers Market Growth & Demand 2025 to 2035
Water Treatment System Market Growth - Trends & Forecast 2025 to 2035
Algae Treatment Chemical Market Growth – Trends & Forecast 2024-2034
Water Treatment Chemical Market Growth – Trends & Forecast 2024-2034
Necrotic Enteritis Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
